Introduction: Guggulu, an oleo gum resin obtained from the bark of Commiphora wightii, has been extensively researched for various medicinal and pharmacological applications, especially within the Indian Ayurvedic system. For human consumption, guggulu undergoes a shodhana process to create Shodhit Guggulu. This refined form of guggulu contains several active phytomolecules that contribute to its pharmacological effects. Historically, guggulu has been used to address numerous health issues, including cardiovascular, dental, neurological, endocrine, reproductive, and infectious conditions. Methods: Review articles and research papers from reputable journals regarding Commiphora wightii have been thoroughly analyzed. Extensive readings and discussions were conducted to summarize researchers' findings concerning the pharmacology and medicinal properties of the phytoconstituents present in the oleo gum. Result: The review explores research discussing the ethnobotanical uses of Commiphora wightii. With the rise in clinical studies and knowledge, guggulu has been thoroughly investigated for its anti- inflammatory, antioxidant, platelet-regulating, thyroid-stimulating, anti-cancer, anti-diabetic, hypolipidemic, neuroprotective, pulmonary-protective, cardioprotective, wound-healing, antimicrobial, and skin-healing properties. Discussion: The resin comprises a complex mixture of volatile oils, terpenoid constituents, minerals, amino acids, polysaccharides, and steroidal derivatives. Safety studies on guggulu have identified specific contraindications and drug interactions, particularly with blood thinners, hypolipidemic agents, and cardiovascular medications. However, the safety profile of guggulu remains limited regarding dosing and clinical studies in pregnant women. Conclusion: Guggulu from Commiphora wightii shows significant pharmacological potential, especially in inflammatory, metabolic, and cardiovascular disorders. While its traditional use is welldocumented, more clinical studies are needed to confirm its safety, efficacy, and to establish standardized dosing for broader therapeutic use.
Rawat et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: